Autonomous Cardiac Pacing and Monitoring System

A next-generation, wearable medical monitoring and treatment device that leverages AI, machine learning, and advanced sensors to provide real-time, personalized cardiac pacing and monitoring, revolutionizing the treatment of cardiac arrhythmias.

The original patent disclosed a non-invasive, bodily-attached ambulatory medical monitoring and treatment device for detecting patient movement to minimize discomfort from pacing pulses. However, this device has limitations in terms of its ability to adapt to changing patient conditions and provide personalized treatment. The new inventive concept addresses these limitations by incorporating advanced technologies to enable autonomous, real-time cardiac pacing and monitoring.

The new inventive concept comprises a wearable device featuring a neural network-based AI system that autonomously detects and adapts to changes in a patient's cardiac activity. The device integrates advanced sensors, including ECG sensing electrodes, to monitor cardiac activity and adjust pacing routines in real-time to optimize treatment outcomes. Additionally, the device may incorporate augmented reality (AR) technology to provide real-time, 3D visualizations of a patient's cardiac activity, enabling more accurate and intuitive diagnosis and treatment. Furthermore, the device may utilize machine learning algorithms to analyze a patient's genomic data, medical history, and real-time physiological data to generate a customized pacing protocol tailored to the individual's unique needs.

The new inventive concept's use of AI, machine learning, and advanced sensors to enable autonomous, real-time cardiac pacing and monitoring represents a significant departure from the original patent's limitations. The incorporation of AR technology and genomic data analysis further distinguish the new inventive concept from existing solutions.

Alternative embodiments of the inventive concept may include the use of swarm robotics, bio-compatible nanochips, or other advanced technologies to enable more precise, localized control over cardiac function. Variations of the device may be designed for specific patient populations, such as pediatric or geriatric patients, or for use in specific medical settings, such as emergency response or remote patient monitoring.

The new inventive concept has significant commercial potential in the medical device industry, particularly in the areas of cardiac rhythm management and patient monitoring. The device may be marketed to hospitals, clinics, and medical research institutions, as well as to individual patients and caregivers. The potential market size is substantial, with the global cardiac rhythm management market projected to reach $25.8 billion by 2025.